covid-19感染后肺诺卡病1例报告并文献复习。

IF 1.9 4区医学 Q4 MICROBIOLOGY

Revista Espanola De Quimioterapia Pub Date : 2023-08-01 Epub Date: 2023-04-27 DOI:10.37201/req/132.2022

J Ortiz, F Jover, V Ortiz de la Tabla, E Delgado

{"title":"covid-19感染后肺诺卡病1例报告并文献复习。","authors":"J Ortiz, F Jover, V Ortiz de la Tabla, E Delgado","doi":"10.37201/req/132.2022","DOIUrl":null,"url":null,"abstract":"In one review of 1050 cases [5] main clinical presentations of nocardiosis were systemic (32 %); pulmonary (only) 39 %; CNS (only) 9 %, cutaneous or lymphocutaneous (8 %) and single site extrapulmonary (egg, eyes, bone) 12 %. The onset of pulmonary nocardiosis may be acute, subacute, or chronic and is not distinguished by any specific signs or symptoms. Fever, night sweats, fatigue, anorexia, weight loss, dyspnea, cough, hemoptysis, and pleuritic chest pain have all been described.","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":"36 4","pages":"421-424"},"PeriodicalIF":1.9000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/d9/revespquimioter-36-421.PMC10336311.pdf","citationCount":"1","resultStr":"{\"title\":\"Pulmonary nocardiosis after covid-19 infection: case report and literature review.\",\"authors\":\"J Ortiz, F Jover, V Ortiz de la Tabla, E Delgado\",\"doi\":\"10.37201/req/132.2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In one review of 1050 cases [5] main clinical presentations of nocardiosis were systemic (32 %); pulmonary (only) 39 %; CNS (only) 9 %, cutaneous or lymphocutaneous (8 %) and single site extrapulmonary (egg, eyes, bone) 12 %. The onset of pulmonary nocardiosis may be acute, subacute, or chronic and is not distinguished by any specific signs or symptoms. Fever, night sweats, fatigue, anorexia, weight loss, dyspnea, cough, hemoptysis, and pleuritic chest pain have all been described.\",\"PeriodicalId\":21232,\"journal\":{\"name\":\"Revista Espanola De Quimioterapia\",\"volume\":\"36 4\",\"pages\":\"421-424\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/d9/revespquimioter-36-421.PMC10336311.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola De Quimioterapia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.37201/req/132.2022\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/4/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Quimioterapia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37201/req/132.2022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 1

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Pulmonary nocardiosis after covid-19 infection: case report and literature review.

查看原文本刊更多论文

Pulmonary nocardiosis after covid-19 infection: case report and literature review.

In one review of 1050 cases [5] main clinical presentations of nocardiosis were systemic (32 %); pulmonary (only) 39 %; CNS (only) 9 %, cutaneous or lymphocutaneous (8 %) and single site extrapulmonary (egg, eyes, bone) 12 %. The onset of pulmonary nocardiosis may be acute, subacute, or chronic and is not distinguished by any specific signs or symptoms. Fever, night sweats, fatigue, anorexia, weight loss, dyspnea, cough, hemoptysis, and pleuritic chest pain have all been described.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Espanola De Quimioterapia 医学-药学

CiteScore

2.90

自引率

10.50%

发文量

146

审稿时长

>12 weeks

期刊介绍： The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine. Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher. All manuscripts are free open access. Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.